Transüretral Prostat Rezeksiyonu Sonrası Medikal Tedaviye Devam Durumunun Öngörülmesinde Preoperatif Prostat Boyutu Belirleyici midir?

Amaç:Benign prostat hiperplazisi (BPH) nedeniyle TURP uygulanan hastaların küçük de olsa bir bölümünde postoperatif alt üriner sistem semptomları (AÜSS) devam etmekte ve bu hastalarda medikal tedaviye devam edilmektedir. Biz de çalışmamızda, TURP uygulanan hastalarda prostat boyutu ile postoperatif ek girişim oranları ve AÜSS nedeniyle medikal tedaviye devam edilme oranları arasında ilişki olup olmadığını araştırdık. Gereç ve yöntem: Preoperatif prostat boyutlarına göre hastalar Grup 1 (prostat hacmi ≥80 ml) ve Grup 2 (prostat hacmi

Does Preoperative Prostate Volume Predictive For Medical Therapy Continuation After Transurethral Prostate Resection?

Purpose:A small proportion of patients who underwent TURP for benign prostate hyperplasia suffer from persistent lower urinary tract symptoms and needs continuing medical treatment. In our study, we aimed to evaluate whether or not is there any relationship between preoperative prostate volume and postoperative persistent LUTS and medical treatment continuation. Materials and methods: The patients were divided into two groups (Group 1: prostate volume ≥80 ml, and Group 2: prostate volume

Kaynakça

Oelke M, Baard J, Wijkstra H, et al. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol 2008;54:419-426.

Yoshimura N, Chancellor MB, Andersson K, et al. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 2005;95:733-738. 16. Kaplan SA. Re: Factors Associated with Continuing Medical Therapy after Transurethral Resection of Prostate. J Urol 2015;194:482.

Ellenberg MAX. Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 1980;92:321-323.

Ransmayr GN1, Holliger S, Schletterer K, Heidler H, Deibl M, Poewe W, Madersbacher H, Kiss G. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Neurology 200822;70:299-303.

Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, Lin YS, Chen CL, Tsui KH. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study. Clin Interv Aging 2017;12:535-541.

Seaman EK, Jacobs BZ, Blaivas JG, Kaplan SA. Persistence or recurrence of symptoms after transurethral resection of the prostate: a urodynamic assessment. J Urol 1994;152:935-7.

Hakenberg OW, Pinnock CB, Marshall VR. Preoperative urodynamic and symptom evaluation of patients undergoing transurethral prostatectomy: analysis of variables relevant for outcome. BJU Int 2003;91:375-9.

Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol 2005;174:1887-1891.

Kakizaki H, Machino R, Koyanagi T. Clinical experience in lower urinary tract symptoms. BJU Int 2001;88:23-26.

Bruskewitz RC, Larsen EH, Madsen PO, Dørflinger T. 3-year follow up of urinary symptoms after transurethral resection of the prostate. J Urol 1986;136:613-615.

Park HK, Paick SH, Lho YS, Jun KK, Kim HG. Effect of the ratio of resected tissue in comparison with the prostate transitional zone volume on voiding function improvement after transurethral resection of prostate. Urology 2012;79:202-206.

Han HH, Ko WJ, Yoo TK, et al. Factors associated with continuing medical therapy after transurethral resection of prostate. Urology 2014;84:675-680.

Joshi HN, De Jong IJ, Karmacharya RM, Shrestha B, Shrestha R. Outcomes of transurethral resection of the prostate in benign prostatic hyperplasia comparing prostate size of more than 80 grams to prostate size less than 80 grams. Kathmandu Univ Med J 2014;12:163-167.

Reich O, Gratzke C, Stief CG. Techniques and longterm results of surgical procedures for BPH. Eur Urol 2006;49:970-978.

Gravas S, Bach T, Bachmann A, et al. EAU 2015 guidelines on the management of non-neurogenic male lower urinary tract tymptoms (LUTS), incl. Benign Prostatic Obstruction (BPO), 2016

Abrams P, Chpple C, Khoury S, Roehrborn C, de La Rosette J. International scientific committee. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol 2009; 81 1779-1787.

Kaynak Göster

  • ISSN: 1309-9833
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2008

1.1b 235